Number of Subjects With Death or Non-fatal Myocardial Infarction Through and Up to Day 30 Baseline to Day 30 [clinicaltrials_resource:0166dbd0546187f49b86bacf8e14dce0]
Death or non-fatal myocardial infarction (MI) after receiving 48 hours of study medication (event date - first dose date) on or before day 30 from baseline. Death: fatal event resulting from any cause. New MI: electrocardiographic (ECG) and or biomarker criteria of myocardial necrosis. Biochemical markers: creatine phosphokinase - myocardial band (CPK-MB) levels and the qualitative troponin-T test.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Subjects With Death or Non-fatal Myocardial Infarction Through and Up to Day 30 Baseline to Day 30 [clinicaltrials_resource:0166dbd0546187f49b86bacf8e14dce0]
Death or non-fatal myocardial infarction (MI) after receiving 48 hours of study medication (event date - first dose date) on or before day 30 from baseline. Death: fatal event resulting from any cause. New MI: electrocardiographic (ECG) and or biomarker criteria of myocardial necrosis. Biochemical markers: creatine phosphokinase - myocardial band (CPK-MB) levels and the qualitative troponin-T test.
Bio2RDF identifier
0166dbd0546187f49b86bacf8e14dce0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0166dbd0546187f49b86bacf8e14dce0
measure [clinicaltrials_vocabulary:measure]
Number of Subjects With Death or Non-fatal Myocardial Infarction Through and Up to Day 30
time frame [clinicaltrials_vocabulary:time-frame]
Baseline to Day 30
description
Death or non-fatal myocardial ...... e qualitative troponin-T test.
identifier
clinicaltrials_resource:0166dbd0546187f49b86bacf8e14dce0
title
Number of Subjects With Death ...... to Day 30 Baseline to Day 30
@en
type
label
Number of Subjects With Death ...... 6dbd0546187f49b86bacf8e14dce0]
@en